PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
25 hedge funds and large institutions have $464M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
75% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 79
Holders
25
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$166M | |
| 2 | +$116M | |
| 3 | +$75M | |
| 4 |
TAA
TB Alternative Assets
Grand Cayman,
Cayman Islands
|
+$12.8M |
| 5 |
PA
Perceptive Advisors
New York
|
+$5.74M |
Top Sellers
| 1 | -$19.6M | |
| 2 | -$13.6M | |
| 3 | -$13M | |
| 4 |
Millennium Management
New York
|
-$12M |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$11.9M |